[ad_1]
of the fund, its portfolio and performance to help you make an informed investment decision.
BASIC FACTS
DATE OF LAUNCH
4 APRIL 2008
CATEGORY
EQUITY
TYPE
LARGE CAP
AUM*
Rs.31,722 crore
BENCHMARK
NIFTY 100 TOTAL
RETURN INDEX
WHAT IT COSTS
NAV**
GROWTH OPTION
Rs.71.96
IDCW
Rs.21.72
MINIMUM INVESTMENT
Rs.5,000
MINIMUM SIP AMOUNT
Rs.1,000
EXPENSE RATIO*** (%)
1.59
EXIT LOAD
1% for redemption within 365 days
*AS ON 30 APRIL 2022
***AS ON 31 MARCH 2022
**AS ON 10 MAY 2022
FUND MANAGER
GAURAV MISRA
TENURE: 3 YEARS, 3 MONTHS
Recent portfolio changes
New Entrants
Asian Paints, , .
Complete Exits
Bharat Petroleum Corporation.
Increasing allocation
EPL, Gland Pharma,
, , HDFC, , Jubilant FoodWorks, , , .
Should you buy?
A multi-cap fund until 2018, this fund was repositioned as a large-cap fund, but moved easily to its new mandate given its historical large-cap bias. The fund retains focus on quality growth names, along with some representation of ideas from the value zone. The portfolio is heavily diversified but retains large positions in its top bets. Along with the change in mandate, the fund also underwent a change in stewardship.
After years of delivering consistent outperformance, the fund’s return profile has visibly slipped of late, owing to two bad years in 2020 and current year. Its superior downside performance has also faltered. Even as the new fund manager needs time to prove execution, investors should be watchful for sustained drag on performance.
(Source: Value Research)
[ad_2]
Source link
